@article{9544a42e396b4763b9da9a80e9913c3c,
title = "A 12-month phase 3 study of pasireotide in Cushing's disease",
abstract = "Cushing's disease is associated with high morbidity and mortality. Pasireotide, a potential therapy, has a unique, broad somatostatin-receptor-binding profile, with high binding affinity for somatostatin-receptor subtype 5.",
keywords = "Adolescent, Adrenocorticotropic Hormone, Adult, Aged, Child, Double-Blind Method, Female, Humans, Hydrocortisone, Male, Middle Aged, Pituitary ACTH Hypersecretion, Recurrence, Saliva, Somatostatin, Young Adult",
author = "Annamaria Colao and Stephan Petersenn and John Newell-Price and Findling, {James W} and Feng Gu and Mario Maldonado and Ulrike Schoenherr and David Mills and Salgado, {Luiz Roberto} and Biller, {Beverly M K} and {Pasireotide B2305 Study Group} and Ulla Feldt-Rasmussen",
year = "2012",
month = mar,
day = "8",
doi = "10.1056/NEJMoa1105743",
language = "English",
volume = "366",
pages = "914--24",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "10",
}